EDS, defined in our study as daytime sleep of >1 h, is associated with many adverse characteristics such as obesity, physical inactivity, diabetes, breathlessness, use of antihypertensive therapy and with an adverse pattern of metabolic risk factors including HbA1c, glucose and insulin. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.